Related references
Note: Only part of the references are listed.Osteopontin Blockade Immunotherapy Increases Cytotoxic T Lymphocyte Lytic Activity and Suppresses Colon Tumor Progression
John D. Klement et al.
CANCERS (2021)
Colorectal adenocarcinoma-derived EGFR mutants are oncogenic and sensitive to EGFR-targeted monoclonal antibodies, cetuximab and panitumumab
Nayoung Kim et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
The Contradictory Role of Interleukin-33 in Immune Cells and Tumor Immunity
Xujun Zhang et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Role of the IL-33/ST2L axis in colorectal cancer progression
Miho Akimoto et al.
CELLULAR IMMUNOLOGY (2019)
Endogenous IL-33 exerts CD8+ T cell antitumor responses overcoming pro-tumor effects by regulatory T cells in a colon carcinoma model
Yulong Xia et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
IL-33 drives influenza-induced asthma exacerbations by halting innate and adaptive antiviral immunity
Lara Ravanetti et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
FcγRIIIb Restricts Antibody-Dependent Destruction of Cancer Cells by Human Neutrophils
Louise W. Treffers et al.
FRONTIERS IN IMMUNOLOGY (2019)
Sonic hedgehog pathway activation is associated with cetuximab resistance and EPHB3 receptor induction in colorectal cancer
Seong Hye Park et al.
THERANOSTICS (2019)
A preliminary analysis of interleukin-1 ligands as potential predictive biomarkers of response to cetuximab
Madelyn Espinosa-Cotton et al.
BIOMARKER RESEARCH (2019)
Cancer stem cells in colorectal cancer: a review
Matthew J. Munro et al.
JOURNAL OF CLINICAL PATHOLOGY (2018)
Amphiregulin-Producing Pathogenic Memory T Helper 2 Cells Instruct Eosinophils to Secrete Osteopontin and Facilitate Airway Fibrosis
Yuki Morimoto et al.
IMMUNITY (2018)
In vitro and clinical data analysis of Osteopontin as a prognostic indicator in colorectal cancer
Ran Wei et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
IL-33/ST2 signaling contributes to radicular pain by modulating MAPK and NF-kappa B activation and inflammatory mediator expression in the spinal cord in rat models of noncompressive lumber disk herniation
Si-Jian Huang et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Natural Killer Cells: Development, Maturation, and Clinical Utilization
Alex M. Abel et al.
FRONTIERS IN IMMUNOLOGY (2018)
Regulatory Mechanisms of IL-33-ST2-Mediated Allergic Inflammation
Hiroaki Takatori et al.
FRONTIERS IN IMMUNOLOGY (2018)
The Pro-tumorigenic IL-33 Involved in Antitumor Immunity: A Yin and Yang Cytokine
Jean-Jacques Fournie et al.
FRONTIERS IN IMMUNOLOGY (2018)
Human osteopontin: Potential clinical applications in cancer
Chengcheng Hao et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2017)
Osteopontin Deficiency Suppresses Intestinal Tumor Development in Apc-Deficient Min Mice
Rikako Ishigamori et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Osteopontin at the Crossroads of Inflammation and Tumor Progression
Luigi Mario Castello et al.
MEDIATORS OF INFLAMMATION (2017)
Colorectal cancer population screening programs worldwide in 2016: An update
Mercedes Navarro et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Serum IL-33 level is a predictor of progression-free survival after chemotherapy
Wenwei Hu et al.
ONCOTARGET (2017)
Osteopontin Promotes Cell Migration and Invasion, and Inhibits Apoptosis and Autophagy in Colorectal Cancer by activating the p38 MAPK Signaling Pathway
Ren-hong Huang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Cetuximab Enhanced the Cytotoxic Activity of Immune Cells during Treatment of Colorectal Cancer
Lin Wang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Interleukin-33 promoting Th1 lymphocyte differentiation dependents on IL-12
Mousa Komai-Koma et al.
IMMUNOBIOLOGY (2016)
Interleukin-33 in tumorigenesis, tumor immune evasion, and cancer immunotherapy
Binfeng Lu et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2016)
Interleukin-33 in health and disease
Foo Yew Liew et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Cetuximab for the treatment of locally advanced and recurrent/metastatic oral cancer: An investigation of distant metastasis
Tomofumi Naruse et al.
MOLECULAR AND CLINICAL ONCOLOGY (2016)
Genetics, diagnosis and management of colorectal cancer
Marina De Rosa et al.
ONCOLOGY REPORTS (2015)
Early skin toxicity predicts better outcomes, and early tumor shrinkage predicts better response after cetuximab treatment in advanced colorectal cancer
T. Kogawa et al.
TARGETED ONCOLOGY (2015)
The Increasing Incidence of Young-Onset Colorectal Cancer: A Call to Action
Dennis J. Ahnen et al.
MAYO CLINIC PROCEEDINGS (2014)
Progression-free survival as a surrogate endpoint for overall survival in glioblastoma: a literature-based meta-analysis from 91 trials
Kelong Han et al.
NEURO-ONCOLOGY (2014)
Transgenic expression of IL-33 activates CD8+ T cells and NK cells and inhibits tumor growth and metastasis in mice
Kun Gao et al.
CANCER LETTERS (2013)
A new nanoconstruct for epidermal growth factor receptor-targeted photo-immunotherapy of ovarian cancer
Youssef Mir et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2013)
Complement Activation and Interleukin Response in Major Abdominal Surgery
A. L. Kvarnstrom et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2012)
IL-33 synergizes with TCR and IL-12 signaling to promote the effector function of CD8+ T cells
Qianting Yang et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
The enigmatic processing and secretion of interleukin-33
Weihua Zhao et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2010)
The effect of colorectal cancer upon host peripheral immune cell function
C. F. M. Evans et al.
COLORECTAL DISEASE (2010)
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
Eric Van Cutsem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Share Paper
